Immunotherapeutic modification of Escherichia coli peritonitis and bacteremia by Iris kashmiriana baker
Abstract
A larger number of medicinal plants and their purified constituents have been shown beneficial therapeutic potentials. We present here the protective effects of an Indian medicinal plant Iris Kashmiriana as compared to Ofloxacin in E. coli induced peritonitis. Iris Kashmiriana is one of an important member of family Iridaceae, locally known as Mazarmund in Kashmir. The plant has been widely used in traditional medicine and modern clinical preparations to treat cold, flu, malaria, toothache, cancer, bacterial, viral infections and bruise. Rats were pre-treated with 200 mg/kg and 400 mg/kg/bwt dose for 3 days and fourth day with E. coli (1×108 CFU/ml) strain and consecutively 3 days treatment. Mortality was monitored for 14 days. After the death of rats or completion of the experiment rats were sacrifice and kidney were used for our protocol. Colonies were count and statically analysis was done. Results showed dose dependent anti-microbial activity. Pretreatment of mice with Iris Kashmiriana improved bacterial clearance as well as improved phagocytic and intracellular bactericidal capacities of neutrophils. In the Ofloxacin treated mice although bacterial clearance was rapid, polymorph phagocytosis was depressed. Thus the results, obtained justify the traditional use of Iris Kashmiriana.
Keywords: Iris kashmiriana, E. coli induced peritonitis, Neutrophils, Ofloxacin.
DOI
https://doi.org/10.22270/jddt.v8i6-s.2064References
Dattner AM. From medical herbalism to phytotherapy in dermatology: back to the future, Dermatologic Therapy, 2003; 16:106-113.
Fong HH. Integration of herbal medicine into modern medical practices: issues and prospects, Integrative Cancer Therapies, 2002; 1:287-293.
Huffman MA. Animal self-medication and ethno-medicine: exploration and exploitation of the medicinal properties of plants, Proceedings of the Nutrition Society, 2003; 62:371-381.
Miller KL, Liebowitz RS, Newby LK. Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches, American Heart Journal, 2004; 147:401-411.
Thatte UM, Rege NN, Phatak SD, Dahanukar SA. The flip side of Ayurveda, Journal of Postgraduate Medicine, 1993; 39:179-82, 182a–b.
Thatte UM, Kulkarni MR, Dahanukar SA. Immunotherapeutic modification of Escherichia coli peritonitis and bacteremia by Tinospora cordifolia, Journal of Postgraduate Medicine, 1992; 38:13-15.
Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine, Phytotherapy Research, 1999; 13:275-291.
Parab S, Kulkarni R, Thatte U. Heavy metals in dherbalT medicines, Indian Journal of Gastroenterology, 2003; 22:111-12.
Salem ML, Hossain MS. Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection, International Journal of Immunopharmacology, 2000;22(9):729-740.
Alexander JW. The role of host defense mechanism in surgical infections, Surgical Clinics of North America, 1980; 60:107-108
Condon RE, Malangoni MA. Peritonitis and intra- abdominal abscesses. In: 'Principles of Surgery'. SI Schwartz, GT Shires, FC Spencer, EH Storer, editors. 4th edition. Singapore: McGraw Hill; 1984, pp 1391-1491
Hadden JW. Immunomodulators in the immunotherapy of cancer and other diseases, Trends in Pharmacology Sciences, 1982; 3:191-194
Drews J. Immunomodulation. In: Recent advances in infection, Vol. 2. DS Reeves, AM Geddes, editors. New York: Churchill Livingstone; 1982, pp 89-100.
Koka JA, Wani AH, Bhat MY, Wani TA, Parveen S. Antimycotic activity of ethanolic and aqueous leaf extracts of Ajuga bracteosa Wall. ex Benth. (Lamiale: Lamiaceae) and Iris kashmiriana Baker (Asparagales: Iridaceae) against some vegetable rot fungi, Brazilian Journal of Biological Sciences, 2018; 5(9):75-84.
Guideline Document on Acute oral Toxicity Testing, Series on Testing and Assessment No. 423. Paris: Organization for Economic Co-Operation and Development, OECD Environment, Health and Safety Publications; 1996. Available from: http//www.oecd.org/ehs.
Teixeira-da-Cunha MG, Gomes RN, Roehrs N, Bozza FA, Prescott SM, Stafforini D et al. Bacterial clearance is improved in septic mice by platelet-activating factor-acetylhydrolase (PAF-AH) administration, PloS one, 2013; 8(9):e74567.
Ikeda F, Wakai Y, Matsumoto SS, Maki K, Watabe E, Tawara S et al. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis, Antimicrobial Agents and Chemotherapy, 2000; 44:614-618.
MacCallum DM, Odds FC. Need for early antifungal treatment confirmed in experimental disseminated candida albicans infection, Antimicrobial Agents and Chemotherapy, 2004; 48(12):4911- 4914.
Rex JH, Nelson PW, Paetznick VL, Lozano-Chiu M, Espinel-Ingroff A, Anaissie EJ. Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis, Antimicrobial Agents and Chemotherapy, 1998; 42(1): 129-134.
Arthington-Skaggs BA, Warnock DW, Morrison CJ. Quantitation of candida albicansergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis, Antimicrobial Agents and Chemotherapy, 2000; 44(8):2081-2085.
Wilkinson PC. Neutrophil Adhesion Test. In Vanejr, Ferraria, S.H., (eds). Handbook of Experimental Pharmacology, Vol. 1, Springer Verlag, Berlin, 1978:109.
Published
Abstract Display: 571
PDF Downloads: 933 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.